共 9 条
[1]
Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy
[J].
ARCHIVES OF ENDOCRINOLOGY METABOLISM,
2018, 62 (02)
:149-156
[2]
de Macedo BM, 2018, ARCH ENDOCRIN METAB, V62, P131, DOI [10.20945/2359-3997000000018, 10.20945/2359.3997000000018]
[3]
Preoperatively undiagnosed papillary thyroid carcinoma in patients thyroidectomized for benign multinodular goiter
[J].
ARCHIVES OF ENDOCRINOLOGY METABOLISM,
2018, 62 (02)
:139-148
[5]
Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials
[J].
EJSO,
2018, 44 (03)
:307-315
[7]
Impact of historic histopathologic sample review on the risk of recurrence in patients with differentiated thyroid cancer
[J].
ARCHIVES OF ENDOCRINOLOGY METABOLISM,
2018, 62 (02)
:157-163
[9]
Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer
[J].
CLINICAL ENDOCRINOLOGY,
2011, 75 (01)
:112-119